Screen First For Optimal IVF Outcomes

Advances in reproductive medicine allow potential parents to identify genetic risks before fertilization or embryo transfer. Genetic screening can detect inherited conditions and chromosomal abnormalities that may affect fertility, pregnancy success, and the long-term health of future children. Understanding the available testing options can guide informed decisions and help create a strong foundation for in vitro fertilization (IVF) or embryo freezing.

Cover your bases with carrier screening

Genetic carrier screening evaluates whether 1 or both partners carry genes linked to specific inherited conditions. Many carriers are healthy and unaware until tested. If parents have a specific gene, the future baby may inherit the condition. Examples of conditions that carrier screening can test for include cystic fibrosis (CF), sickle cell disease, and fragile X syndrome. Testing can be targeted based on family history or comprehensive, covering hundreds of conditions. Results help couples decide whether to proceed with IVF using personal eggs and sperm or a donor. In some cases, advanced embryo screening is used to ensure that the embryo chosen for transfer during IVF did not inherit the genetic condition.

The value of PGT-A and PGT-M

Preimplantation genetic testing (PGT) is performed on embryos created through IVF to identify chromosomal or genetic abnormalities. Preimplantation genetic testing for aneuploidy (PGT-A) screens embryos for chromosomal abnormalities, a leading cause of miscarriage. Preimplantation genetic testing for monogenic disorders (PGT-M) screens for specific single-gene disorders, like CF, when 1 or both parents are known carriers. The process involves removing a small cell sample from the early embryo for testing. Choosing genetically healthy embryos can increase implantation rates and reduce the risk of genetic disease.

Link between screening and fertility planning

Completing genetic screening before freezing eggs, sperm, or embryos can influence both immediate and long-term reproductive planning. Early results may shape decisions about whether to create embryos now, store unfertilized eggs, or consider donor gametes. Screening before fertilization can also prevent unnecessary costs and procedures if significant risks are identified. This proactive approach provides clarity and reduces uncertainty in the IVF process.

Improving pregnancy outcomes

Selecting embryos without chromosomal abnormalities can improve the likelihood of successful implantation, ongoing pregnancy, and a healthy birth. Screening also reduces the emotional and physical toll of repeated failed cycles or pregnancy loss. For couples with a known genetic disorder in the family, avoiding the transfer of affected embryos helps prevent the risk of serious health conditions in the future child.

Take the next step with confidence

Genetic screening offers valuable insight for any individual considering embryo freezing or IVF. Testing is a personal decision influenced by family history, age, reproductive goals, and medical guidance. Selecting a fertility clinic with advanced laboratory capabilities ensures accurate results and appropriate counseling. By identifying potential issues early, genetic screening supports a more informed, efficient, and emotionally prepared path to parenthood.